drugset / Trial / NCT01554540

Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study

NCT01554540

Phase 1/2 Unknown 40 enrolled University Hospital, Grenoble
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to assess skin blood flow after non-invasive local administration of treprostinil by using a low-intensity current (i.e. iontophoresis) on the forearm and the fingers of healthy volunteers and patients with systemic sclerosis. The investigators also aim at assessing the systemic bioavailability and dermal diffusion of treprostinil iontophoresis.

Timeline

Start
2012-02
Primary completion
2013-10
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Treprostinil Other / unclassified 0.1 mg/ml Other

Indications